Richard Brudnick News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Richard brudnick. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Richard Brudnick Today - Breaking & Trending Today

Scholar Rock Reports First Quarter 2023 Financial Results and Highlights Business Progress

- Enrollment of pivotal Phase 3 SAPPHIRE trial evaluating apitegromab on track for completion in 2023

- Upcoming presentations of 36-month apitegromab data from Phase 2 TOPAZ trial at Cure. | May 9, 2023 ....

United States , Ted Myles , Jay Backstrom , Richard Brudnick , Muscular Dystrophy Association , Exchange Commission , Scholar Rock Inc , Research Clinical Conference , Scholar Rock Holding Corporation , Scholar Rock , Chief Executive Officer , Company Highlights , Clinical Conference , Dystrophy Association , Scientific Conference , European Society , Medical Oncology Targeted Anticancer Therapies , Chief Operating Officer , Chief Financial Officer , Securities Act , Private Securities Litigation Reform Act , Quarterly Report , Consolidated Statements , Months Ended March , Scholar Rock Holding Corporation Stock Exchange , Press Release ,

Scholar Rock Announces the Addition of Richard Brudnick to Its Board of Directors

CAMBRIDGE, Mass. (BUSINESS WIRE) Scholar Rock (NASDAQ: SRRK), a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced that Richard Brudnick, has been appointed to Scholar Rock’s Board of Directors as an. ....

United Kingdom , Richard Brudnick , Tamarix Pharma , Codiak Biosciences , Rushmie Nofsinger , David Hallal , Teagan White , Exchange Commission , Alliance Management At Bioverativ , Scholar Rock Inc , Business Development , Scholar Rock , Chief Business Officer , Prime Medicine , Executive Vice President , Alliance Management , Management Science , Massachusetts Institute , Technology Sloan School , Securities Act , Private Securities Litigation Reform Act , Annual Report ,

Scholar Rock Holding (SRRK) Announces the Addition of Richard Brudnick to Its Board of Directors

Scholar Rock Holding (SRRK) Announces the Addition of Richard Brudnick to Its Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Codiak Biosciences , Richard Brudnick , David Hallal , Tamarix Pharma , Business Development , Alliance Management At Bioverativ , Scholar Rock , Chief Business Officer , Prime Medicine , Executive Vice President , Alliance Management , Management Science , Massachusetts Institute , Technology Sloan School ,

Volition Rx Limited (VNRX) Q1 2021 Earnings Call Transcript

Operator
Good morning, ladies and gentlemen. Thank you for standing by. Welcome to VolitionRx Limited First Quarter 2021 Earnings Conference Call.
[Operator Instructions]
This conference is being recorded today, May 12, 2021. I would now like to turn the conference call over to Mr. Scott Powell, Executive Vice President of Investor Relations. Please go ahead.
Scott Powell
Executive Vice President, Investor Relations & Chief Financial Officer of Volition America, Inc.
Thank you, and welcome everyone to today s earnings conference call for VolitionRx Limited. This call will cover Volition s financial and operating results for the first quarter of 2021, along with a discussion of our recent activities and key upcoming milestones. Following our prepared remarks, we will open the conference call to a question-and-answer session. On our call today are Mr. Cameron Reynolds, President and Chief Executive Officer; Mr. Terig Hughes, our Chief Financial Officer. ....

United States , United Kingdom , City Of , Nathan Weinstein Agesi , Michael Okunewitch , Kyle Mikson , Bruce Jackson , Kyle Mikson Cantor Fitzgerald , Cameron Reynolds , Tom Butera , Terig Hughes , Kim Nguyen , Jake Micallef , Jason Mccarthy , Scott Powell , Nathan Weinstein , Andrew Aswani , Gaetan Michel , Mark Eccleston , Richard Brudnick , Heather Wilson Robles , Volition America Inc , Terig Hughes Group , Maxim Group , National Taiwan University , Cantor Fitzgerald ,

VolitionRx Limited Announces First Quarter 2021 Financial Results and Business Update

VolitionRx Limited Announces First Quarter 2021 Financial Results and Business Update
Conference call to discuss financial and operational results scheduled for Wednesday, May 12, at 8:00 a.m. U.S. Eastern Time
News provided by
Share this article
Strengthened the Company s leadership team to drive commercial focus
Expanded the Company s intellectual property portfolio
Initiated production of product components at scale at the Company s Silver One facility
Published three clinical papers
Continued focus on product launches and licensing in both the human and veterinary spaces
AUSTIN, Texas, May 11, 2021 /PRNewswire/ VolitionRx Limited (NYSE AMERICAN: VNRX) ( Volition ) today announced financial results and a business update for the first quarter ended March 31, 2021. Volition management will host a conference call tomorrow, May 12 at 8:00 a.m. U.S. Eastern Time to discuss these results. Conference call details may be found below. ....

United States , United Kingdom , City Of , Scott Powell , Richard Brudnick , Cameron Reynolds , Tom Butera , Terig Hughes , Kim Nguyen , Exchange Commission , National Taiwan University , Toll International , Technology Officer , Securities Exchange , Service Lab In Silver , Volitionrx Limited First Quarter , Chief Executive Officer , Chief Financial , Walloon Regional Government , Chief Financial Officer , Gael Forterre , Chief Commercial , Gaetan Michel , Chief Operating Officer , Mark Eccleston , Chief Technology ,